HLA in Narcolepsy

[1]  G. Mueller‐Eckhardt,et al.  HLA and narcolepsy in a German population. , 2008, Tissue antigens.

[2]  J. Dausset,et al.  HLA and multiple sclerosis: population and families study. , 2008, Tissue antigens.

[3]  G. Thomson.  The mode of inheritance of the HLA-linked gene predisposing to narcolepsy. , 2008, Tissue antigens.

[4]  M. Billiard,et al.  Possible association between HLA-B7 and narcolepsy. , 2008, Tissue antigens.

[5]  G. Stewart,et al.  Strong linkage disequilibrium between HLA-Dw2 and and BfS in multiple sclerosis and in the normal population. , 2008, Tissue antigens.

[6]  H. Mcdevitt,et al.  HLA-D antigens in the Japanese population. , 2008, Tissue antigens.

[7]  J. Montplaisir,et al.  Narcolepsy in monozygotic twins , 1987, Neurology.

[8]  Eric O Long,et al.  Mapping of the class II region of the human major histocompatibility complex by pulsed-field gel electrophoresis , 1986, Nature.

[9]  K. Šonka,et al.  DR2–NEGATIVE NARCOLEPSY , 1986, The Lancet.

[10]  W. Ollier,et al.  HLA-Dw specificity assignments are independent of HLA-DQ, HLA-DR, and other class II specificities and define a biologically important segregant series which strongly activates a functionally distinct T cell subset. , 1986, Human immunology.

[11]  J. Ilonen,et al.  Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens. , 1986, Immunobiology.

[12]  D. Vergani,et al.  Immune factors in narcolepsy. , 1986, Sleep.

[13]  H. Inoko,et al.  HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. , 1986, Sleep.

[14]  F. Bach,et al.  DNA restriction fragment length polymorphisms characteristic for Dw subtypes of DR2. , 1986, Human immunology.

[15]  M. Baur,et al.  Homogeneity of HLA-DQ,DR phenotypes in lymphocyte subsets of normal individuals. , 1986, Human immunology.

[16]  R. Godbout,et al.  Nocturnal sleep of narcoleptic patients: revisited. , 1986, Sleep.

[17]  W. Dement,et al.  Muscarinic cholinergic receptors and the canine model of narcolepsy. , 1986, Sleep.

[18]  C. Ninomiya,et al.  Increased frequency of non-insulin-dependent diabetes mellitus among narcoleptic patients. , 1986, Sleep.

[19]  A. Besset,et al.  HLA-DR2 and narcolepsy. , 1986, Sleep.

[20]  J. Parkes,et al.  Narcolepsy and immunity. , 1986, British medical journal.

[21]  R. Godbout,et al.  The effect of zimelidine, a serotonin-reuptake blocker, on cataplexy and daytime sleepiness of narcoleptic patients. , 1986, Clinical neuropharmacology.

[22]  M. Satake,et al.  Human histocompatibility leukocyte antigen (HLA) haplotype frequencies estimated from the data on HLA class I, II, and III antigens in 111 Japanese narcoleptics. , 1985, The Journal of clinical investigation.

[23]  S. Schleifer,et al.  Stress and immunomodulation: the role of depression and neuroendocrine function. , 1985, Journal of immunology.

[24]  J. M. Boss,et al.  Genetic Complexity and Expression of Human Class II Histocompatibility Antigens , 1985, Immunological reviews.

[25]  R. Spielman,et al.  Structure, Sequence and Polymorphism in the HLA‐D Region , 1985, Immunological reviews.

[26]  C. Auffray,et al.  Gene organization of DC and DX subregions of the human major histocompatibility complex. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Baur,et al.  Histocompatibility Testing 1984 , 1985, Springer Berlin Heidelberg.

[28]  M. Satake,et al.  EXTRAORDINARY ASSOCIATION BETWEEN HLA-DR2 AND NARCOLEPSY , 1985, The Lancet.

[29]  J. Dausset,et al.  Clusters of HLA class II beta restriction fragments describe allelic series. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Vaughan,et al.  GENETIC MARKERS IN NARCOLEPSY , 1984, The Lancet.

[31]  M. Satake,et al.  HLA antigens in Japanese patients with narcolepsy , 1984 .

[32]  C. Brautbar,et al.  Definition of a new DR2 short associated HLA-D specificity with the Ninth Histocompatibility Workshop reagents. , 1984, Tissue antigens.

[33]  L. Strong,et al.  Human C4 haplotypes with duplicated C4A or C4B. , 1984, American journal of human genetics.

[34]  E. Yunis,et al.  An unusual "morphologic" variant of BF S. , 1984, American journal of human genetics.

[35]  Charles Auffray,et al.  The class II molecules of the human and murine major histocompatibility complex , 1984, Cell.

[36]  D. Larhammar,et al.  Exon-intron organization and complete nucleotide sequence of a human major histocompatibility antigen DC beta gene. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  H. Cann,et al.  Analysis of HLA class I genes with restriction endonuclease fragments: implications for polymorphism of the human major histocompatibility complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. A. Peterson,et al.  Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Bodmer,et al.  Sequences related to HLA-DR alpha chain on human chromosome 6: restriction enzyme polymorphism detected with DC alpha chain probes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Kaufman,et al.  The extracellular region of light chains from human and murine MHC class II antigens consists of two domains. , 1983, Journal of immunology.

[41]  D. Larhammar,et al.  Complete amino acid sequence of an HLA-DR antigen-like beta chain as predicted from the nucleotide sequence: similarities with immunoglobulins and HLA-A, -B, and -C antigens. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[42]  D. Meyers,et al.  HLA-Dw2: a genetic marker for human immune response to short ragweed pollen allergen Ra5. I. Response resulting primarily from natural antigenic exposure , 1982, The Journal of experimental medicine.

[43]  J. McNally,et al.  EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.

[44]  E. Poole.  Diagnostic classification of sleep and arousal disorders—sleep Vol. 2, no. 1. 137 pp. Raven Press, New York (1979) $15.00 , 1981, Neuroscience.

[45]  B. Benacerraf.  Role of MHC gene products in immune regulation. , 1981, Science.

[46]  C. Rittner,et al.  On the significance of C2, C4, and factor B polymorphisms in disease , 1981, Human Genetics.

[47]  G. Hauptmann,et al.  A hemolytically inactive gene product of factor B. , 1980, Immunobiology.

[48]  A. Vincent,et al.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. , 1980, Brain : a journal of neurology.

[49]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Seignalet.  Recherche d'anticorps anti-cellules B et typages HLA-DR à Montpellier , 1980 .

[51]  M. Mamelak,et al.  Narcolepsy: a family study. , 1979, Biological psychiatry.

[52]  J. Parkes,et al.  Genetic study of narcoleptic syndrome. , 1978, Journal of medical genetics.

[53]  G. Hauptmann,et al.  The nomenclature of properdin factor B allotypes. , 1978, Zeitschrift fur Immunitatsforschung. Immunobiology.

[54]  P. Terasaki,et al.  Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. , 1978, American journal of clinical pathology.

[55]  J. Atkinson,et al.  Mapping of the HLA locus controlling C2 structural variants and linkage disequilibrium between alleles C22 and Bw15 , 1976 .

[56]  I. Peart,et al.  Unilateral cataplexy associated with systemic lupus erythematosus , 1976, Journal of neurology, neurosurgery, and psychiatry.

[57]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[58]  C. Guilleminault,et al.  A FAMILY STUDY OF 50 REM NARCOLEPTICS , 1974, Acta neurologica Scandinavica.

[59]  E. Albert,et al.  Population genetics of the MLC response: typing for MLC determinants using homozygous and heterozygous reference cells. , 1973, Transplantation proceedings.

[60]  D. B. Amos,et al.  Three closely linked genetic systems relevant to transplantation. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[61]  D. B. Amos,et al.  PHENOTYPIC EXPRESSIONS OF THE MAJOR HISTOCOMPATIBILITY LOCUS IN MAN (HL-A): LEUKOCYTE ANTIGENS AND MIXED LEUKOCYTE CULTURE REACTIVITY , 1968, The Journal of experimental medicine.

[62]  L. Old,et al.  GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS. , 1964, Lancet.

[63]  W. Donnelly,et al.  Differences between lymphocytes of leukemic and non-leukemic patients with respect to morphologic features, motility, and sensitivity to guinea pig serum. , 1961, Blood.

[64]  N. Imlah.  NARCOLEPSY IN IDENTICAL TWINS , 1961, Journal of neurology, neurosurgery, and psychiatry.

[65]  E. Cambau.  HLA et maladies , 1988 .

[66]  J. Montplaisir,et al.  HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. , 1986, Sleep.

[67]  J. Dausset,et al.  Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosis. , 1985, Immunogenetics.

[68]  W. Ollier,et al.  HLA-D and DR in Different Populations , 1984 .

[69]  L. Degos,et al.  HLA-DR, DQ, and Dw Relationships , 1984 .

[70]  R. Porter.  Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation. , 1983, Molecular biology & medicine.

[71]  B. Roth,et al.  Heredofamilial aspects of narcolepsy and hypersomnia. , 1972, Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie.

[72]  D. Daly,et al.  A family with narcolepsy. , 1959, Proceedings of the staff meetings. Mayo Clinic.